Elixinol Wellness Limited (ELLXF)
Elixinol Wellness Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Sydney, VIC, AU. The stock last traded at $0.00, down 54.34% on the session, giving a market capitalisation of $869,600. On trailing twelve-month figures it carries a trailing P/E of -0.30, a net margin of -35.4%. Its beta of 2.20 implies it has historically moved more than the broad market.
Elixinol Wellness Limited, an Australian-based company established in 2017 with its headquarters in Sydney, operates as a global producer and supplier of hemp-derived products. The firm crafts and distributes a diverse range of hemp-based wellness, beauty, and food items, marketed under its well-known Elixinol and Hemp Foods Australia brands. Its comprehensive product portfolio encompasses cannabidiol (CBD) products, dietary supplements, various food items, topicals, and skincare solutions. These offerings reach consumers across significant international markets, including the Americas, Europe, and Australia. The company officially adopted its current name, Elixinol Wellness Limited, in May 2021, having previously been known as Elixinol Global Limited.
Elixinol Wellness Limited is most often compared with the following Healthcare names: